Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets    
Cash and cash equivalents $ 116,854 $ 124,242
Total short-term investments 0 43,690
Accounts receivable, net of allowance for expected credit losses ($360 and $1,559, respectively) 24,059 29,294
Inventory 26,773 26,409
Prepaid expenses 2,756 2,847
Other current assets 2,022 3,334
Total current assets 172,464 229,816
Property and equipment, net 17,713 18,298
Intangible assets, net 17,128 17,626
Goodwill 0 31,116
Right-of-use asset 36,884 45,955
Other assets 3,763 3,130
Total assets 247,952 345,941
Current liabilities    
Accounts payable 13,235 14,425
Accrued expenses 9,840 9,663
Deferred revenue 8,779 8,854
Lease liability 7,368 8,022
Other current liabilities 1,526 0
Total current liabilities 40,748 40,964
Long-term deferred revenue 6,083 5,358
Contingent earnout liability 1,379 2,415
Long-term lease liabilities 35,771 40,608
Other liabilities 2,361 4,042
Total liabilities 86,342 93,387
Commitments and contingencies (Note 15)
Stockholders' equity    
Common stock, $0.0001 par value; 1,000,000,000 shares authorized at December 31, 2023 and December 31, 2022; 198,581,263 and 194,560,946 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively 19 19
Additional paid-in capital 366,281 352,564
Accumulated deficit (204,664) (101,097)
Accumulated other comprehensive (loss) income (26) 1,068
Total stockholders' equity 161,610 252,554
Total liabilities and stockholders' equity $ 247,952 $ 345,941